Digitek is prescribed to treat patients with an irregular heartbeat or congestive heart failure. In 2006 and 2007, the FDA sent warning letters to Actavis Totowa, the manufacturer of Digitek, about violations of “Good Manufacturing Practices” at the New Jersey plant where Digitek and other drugs were produced. The FDA was correct in their concern that drugs were not being manufactured at their proper strength, and in April 2008 a nationwide recall of Digitek was issued due to some tablets being twice the normal dose. Digitek users receiving a double dose of the drug could have suffered serious and potentially fatal side-effects including heart attack, stroke, or damage to the heart.

If you or a loved one has been prescribed Digitek, contact us immediately.